These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8613428

  • 1. Genomic organization of human papillomavirus type 18 in cervical cancer specimens.
    Kitagawa K, Yoshikawa H, Onda T, Kawana T, Taketani Y, Yoshikura H, Iwamoto A.
    Jpn J Cancer Res; 1996 Mar; 87(3):263-8. PubMed ID: 8613428
    [Abstract] [Full Text] [Related]

  • 2. Genital papillomavirus in Greek women with high-grade cervical intraepithelial neoplasia and cervical carcinoma.
    Labropoulou V, Diakomanolis E, Dailianas S, Kalpaktsoglou K, Rodolakis A, Beaudenon S, Kakkanas A, Mavromara P.
    J Med Virol; 1996 Jan; 48(1):80-7. PubMed ID: 8825715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The role of human papillomavirus in cyto-histological practice: distribution and prevalenceof hig-risk strains (16, 18, 31, 33, and 35) in intraepithelial lesions and neoplasia of the uterine cervix].
    Voglino G, Poso F, Privitera S, Parisio F, Ghiringhello B, Gordini G, Chiara G, Massobrio M, Fessia L.
    Pathologica; 2000 Dec; 92(6):516-23. PubMed ID: 11234302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung.
    Kinoshita I, Dosaka-Akita H, Shindoh M, Fujino M, Akie K, Kato M, Fujinaga K, Kawakami Y.
    Br J Cancer; 1995 Feb; 71(2):344-9. PubMed ID: 7841051
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
    Kaufmann AM, Stern PL, Rankin EM, Sommer H, Nuessler V, Schneider A, Adams M, Onon TS, Bauknecht T, Wagner U, Kroon K, Hickling J, Boswell CM, Stacey SN, Kitchener HC, Gillard J, Wanders J, Roberts JS, Zwierzina H.
    Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
    [Abstract] [Full Text] [Related]

  • 9. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB.
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [Abstract] [Full Text] [Related]

  • 10. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers.
    Yoshinouchi M, Hongo A, Nakamura K, Kodama J, Itoh S, Sakai H, Kudo T.
    J Clin Microbiol; 1999 Nov; 37(11):3514-7. PubMed ID: 10523544
    [Abstract] [Full Text] [Related]

  • 11. The role of p53 inactivation in human cervical cell carcinoma development.
    Miwa K, Miyamoto S, Kato H, Imamura T, Nishida M, Yoshikawa Y, Nagata Y, Wake N.
    Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
    Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.
    Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.
    Mol Diagn; 2004 Feb; 8(1):57-64. PubMed ID: 15230643
    [Abstract] [Full Text] [Related]

  • 14. DEK overexpression in uterine cervical cancers.
    Wu Q, Li Z, Lin H, Han L, Liu S, Lin Z.
    Pathol Int; 2008 Jun; 58(6):378-82. PubMed ID: 18477217
    [Abstract] [Full Text] [Related]

  • 15. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
    Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.
    Int J Gynecol Cancer; 2001 Jun; 11(1):39-48. PubMed ID: 11285032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ, Herrero R.
    Int J Cancer; 2003 Oct 20; 107(1):127-33. PubMed ID: 12925967
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix.
    Teshima H, Beaudenon S, Koi S, Katase K, Hasumi K, Masubuchi K, Orth G.
    Arch Gynecol Obstet; 1997 Oct 20; 259(4):169-77. PubMed ID: 9271836
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.